cerca CERCA
Giovedì 22 Aprile 2021
Aggiornato: 16:36
Temi caldi


Sommet Education duplica la sua presenza globale con l'acquisizione di Invictus Education Group, istituto privato leader nella formazione in Sud Africa

LAUSANNE, Svizzera, 21 aprile 2021 /PRNewswire/ -- Sommet Education, primaria rete internazionale di scuole specializzata nella formazione in hospitality management e arti culinarie, e Invictus Education Group, istituto privato sudafricano leader nella formazione, ufficializzano l'acquisizione di Sommet Education della quota di maggioranza di Invictus Education, accanto ai suoi azionisti storici. Con questa operazione Sommet Education raddoppia la sua presenza a livello mondiale, portando da 9 a ...

Kharon And WiseTech Global Partner To Expose Hidden Risk In Sanctions Compliance

LOS ANGELES, April 21, 2021 /PRNewswire/ -- Kharon, the research and data analytics company focused on security threats and other controversies that impact global commerce and finance, and WiseTech Global, leading developer and provider of software solutions to the logistics industry globally, today announced they have partnered to boost sanctions and risk compliance by offering clients access to more precise intelligence.

CGTN: China's voices at Boao: Multilateralism, openness and BRI

BEIJING, April 21, 2021 /PRNewswire/ -- With the world in the midst of a coronavirus-induced economic and health crisis, China has called on all countries in Asia and beyond to uphold multilateralism, embrace openness, and enhance Belt and Road cooperation.

HUAWEI AppGallery Connect Unveiled New Logo

SHENZHEN, China, April 21, 2021 /PRNewswire/ -- AppGallery Connect, the app service platform provided by HUAWEI AppGallery, has unveiled its new logo. The design of the logo is inspired by the angle brackets (<>), two symbols frequently used in coding. The two angle brackets are closely connected to form a square, conveying the message that AppGallery Connect is dedicated to deepen the partnership with the developers to jointly build innovative apps.

Bank of Montreal to Redeem $1,250,000,000 3.32% Series I Medium-Term Notes First Tranche (Non-Viability Contingent Capital (NVCC))

TORONTO, April 20, 2021 /PRNewswire/ -- Bank of Montreal (TSX: BMO)(NYSE: BMO) today announced that it intends to redeem all of its $1,250,000,000 3.32% Series I Medium-Term Notes First Tranche (Non-Viability Contingent Capital) due June 1, 2026 (the "Notes"). The redemption will occur on June 1, 2021 (the "Redemption Date"). The Notes are redeemable at par together with accrued and unpaid interest to, but excluding, the Redemption Date. Interest on the Notes will cease to accrue from and after t...

Humboldt Seed Company Partners With Nymera to Offer World's First Feminized, Organic-Certified Cannabis Seeds to Canadian and Global Markets

HUMBOLDT COUNTY, Calif., April 20, 2021 /PRNewswire/ -- Humboldt Seed Company, the largest legal cannabis seed seller in California, is proud to announce its partnership with British Columbia-based Nymera to offer the first feminized, organic-certified seeds in the world to Canadian and global markets. For the first time, Canadian LPs will have ready and consistent access to these time-tested heritage genetics and new varietals.

Precision NanoSystems Announces New Cell Therapy Reagent for Lipid Nanoparticle -based mRNA Delivery to T Cells

VANCOUVER, BC, April 20, 2021 /PRNewswire/ -- Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, today launched the GenVoy-ILM™ T Cell Kit for mRNA to enable lipid nanoparticle (LNP)-based ex vivo gene transfer. Scientists can now use mRNA-LNP to efficiently and reproducibly generate high yields of engineered primary human T cells using a simple workflow.

GW Pharmaceuticals riceve l'approvazione della Commissione Europea per EPIDYOLEX® (cannabidiolo) per il trattamento delle crisi associate al complesso della sclerosi tuberosa

LONDRA, 20 aprile 2021 /PRNewswire/ -- GW Pharmaceuticals plc annuncia oggi che la Commissione Europea ha approvato la domanda di variazione di Tipo II per EPIDYOLEX® (cannabidiolo) come trattamento aggiuntivo delle crisi associate alla TSC per pazienti a partire dai due anni. Questa approvazione, che rappresenta la terza indicazione per il farmaco a base di cannabidiolo di GW, apre la strada al lancio del farmaco in tutta Europa.

ora in
Prima pagina
Tag più usati
in questa pagina



ict ict economia_e_finanza






in Evidenza